Close vascularization implant material

Details Close vascularization implant material Close vascularization implant material

1995-06-07

1998-09-01

Isabella, David

Prosthesis (i.e., artificial body members), parts thereof, or ai

Implantable prosthesis

623 12, 424422, 424424, 4352971, 6048911, 6048901, A61F 202, A61F 922, A61F 200

Patent

active

058005293

ABSTRACT:
A device for implantation in a host having a material at an interface between the host and the device, said material having a conformation which results in growth of vascular structures by the host close to the interface.

REFERENCES:
patent: 3967818 (1976-07-01), Zaffaroni
patent: 3993072 (1976-11-01), Zaffaroni
patent: 4011861 (1977-03-01), Enger
patent: 4229838 (1980-10-01), Mano
patent: 4266999 (1981-05-01), Baler
patent: 4298002 (1981-11-01), Ronel et al.
patent: 4306318 (1981-12-01), Mano et al.
patent: 4309776 (1982-01-01), Berguer
patent: 4309996 (1982-01-01), Theeuwes
patent: 4321711 (1982-03-01), Mano
patent: 4352883 (1982-10-01), Lim
patent: 4353888 (1982-10-01), Sefton
patent: 4374669 (1983-02-01), Mac Gregor
patent: 4378016 (1983-03-01), Loeb
patent: 4391909 (1983-07-01), Lim
patent: 4475916 (1984-10-01), Himmelstein
patent: 4487768 (1984-12-01), Goosen et al.
patent: 4508113 (1985-04-01), Malaney
patent: 4542539 (1985-09-01), Rowe et al.
patent: 4553272 (1985-11-01), Mears
patent: 4576608 (1986-03-01), Homsy
patent: 4578191 (1986-03-01), Jaffrin et al.
patent: 4601893 (1986-07-01), Cardinal
patent: 4620286 (1986-10-01), Nyiias et al.
patent: 4657544 (1987-04-01), Pinchuk
patent: 4664669 (1987-05-01), Ohyabu et al.
patent: 4670286 (1987-06-01), Nyilas et al.
patent: 4673566 (1987-06-01), Goosen et al.
patent: 4686098 (1987-08-01), Kopchick et al.
patent: 4689293 (1987-08-01), Goosen et al.
patent: 4712553 (1987-12-01), MacGregor
patent: 4743252 (1988-05-01), Martin, Jr. et al.
patent: 4795459 (1989-01-01), Jauregui
patent: 4798585 (1989-01-01), Inoue et al.
patent: 4803168 (1989-02-01), Jarvis, Jr.
patent: 4804381 (1989-02-01), Turina et al.
patent: 4806355 (1989-02-01), Goosen et al.
patent: 4816339 (1989-03-01), Tu et al.
patent: 4822361 (1989-04-01), Okita et al.
patent: 4871366 (1989-10-01), Von Recum et al.
patent: 4877029 (1989-10-01), Valentini et al.
patent: 4878913 (1989-11-01), Aebischer et al.
patent: 4892538 (1990-01-01), Aebischer et al.
patent: 4911717 (1990-03-01), Gaskill, III
patent: 4922926 (1990-05-01), Hirschberg et al.
patent: 4936317 (1990-06-01), MacGregor
patent: 4950483 (1990-08-01), Ksander et al.
patent: 4990138 (1991-02-01), Bacich et al.
patent: 5002572 (1991-03-01), Picha
patent: 5002661 (1991-03-01), Chick et al.
patent: 5024670 (1991-06-01), Smith et al.
patent: 5026365 (1991-06-01), Rossini et al.
patent: 5035891 (1991-07-01), Runkel et al.
patent: 5077215 (1991-12-01), McSuslan et al.
patent: 5182111 (1993-01-01), Aebischer et al.
patent: 5219361 (1993-06-01), Von Recum
Macroporous Hydrogel Membranes for a Hybrid Artificial Pancreas. II. Biocompatibility: Klomp et al., Jrnl of Biomedical Mat. Res., vol. 17, 865-871 (1983).
Oxygen Tension Regulates the Expression of Angiogenesis Factor by Macrophages; Knighton et al., Science, 1981.
Macrophage-derived Growth Factors in Wound Healing: Regulation of Growth Factor Production by the Oxygen Microenvironment; Knighton et al., Am. Rev. Respir. Dis. 1989; 140:1108-1111.
Activated Macrophages Induce Vascular Proliteration; Piverini et al., Nature, vol. 269, pp. 804-806, Oct. 27, 1977.
Japanese Abstract of 8078845 assigned to Fujisawa Pharm KK & Kyoto Ceramic KK.
Anderson J. "Inflammatory Response to Implants," vol. XXXIV Trans. Am. Soc. Artif. Intern. Organs, 1988.
Christenson et al., "Tissue of Cortippid and Doxorubicin," J of Biomed Mat Res. 23, pp. 705-718 (1989).
Schrap, D. et al., "Islet Immuno-Isolation: The Use of Hybrid Artificial Organs to Prevent Islet Tissue Immuno-Isolation;" World J. Surg 8 pp. 221-229 (1984).
Ratner, B., "New ideas in biomaterials science-a path to engineered biomaterials:" Journal of Biomedical Materials Research, vol. 27, pp. 837-850 (1993).
Campbell, C.D., "Expanded microporous polytetrafluoroethylene as a vascular substitute: A two year follow-up:" Surgery 95, pp. 1770183 (1979).
Squier, C.A., "The relationship between soft tissue attachment, epithelial downgrowth and surface porosity;" Journal of Periodontal Research 16, pp. 434-440, 1981.
Wasfiee, T. et al., "Inhibition of Epithelial Downgrowth on Percutaneous Access Devices inSwind; II;" Trans Am Soc Artif Intern Organs, vol. XXX, pp. 556-560, (1984).
Eskin, S. G. et al., "Endothelial Cell Culture on Dacron Fabrics of Different Configurations;" Journal of Biomedical Materials Research, vol. 12, pp. 517-524 (1978).
Royce, B., "Physical Characteristics of Expanded Polytstrsfluoroethylene Grafts: Biologic and Synthetic Vascular Proethsers," pp. 863-869 (1962).
Campell, C. et al., "A Small Arterial Substitute: Expanded Microporous Polytetrafluoroethylene: Potency Versus Porosity," Annals of Surgery, pp. 136-143 (1976).
Bioengineering in Development of the Hybrid Artificial Pancreas; C.K. Colton et al., Transactions of the ASME, vol. 113, May 1991.
Texturing of Polmer Surfaces at the Cellular Level, J.A. Schmidt et al., Biomaterials, vol. 12, May, 1991.
Microtopography and Soft Tissue Response: C.E. Campbell et al., Journal of Investigative Surgery, vol. 2, pp. 51-74, 1991.
Brauker, J. et al., "Neovascularization at a Membrane--Tissue Interface is Dependent on Microarchitecture, "New Ideas . . . : p. 546.
Freed, P.S., "Long-Term Percutaneous Access Device;" Trans AM Soc Artif Intern Organs, vol. XXXI, pp. 230-232 (1985).
Chehroudi, B. et al, "Effects of a grooved epoxy substratum on epithelial cell behavior in vitro and in vivo;" Journal of Biomedical Materials Research, vol. 22, pp. 459-473 (1988).
Weaver, J.M. et al., "The Growth of Cells in Diffusion Chambers. II. The Role of Cells in the Destruction of Homografts in Mice:" Journal of the National Cancer Institute, vol. 15 No. 6, pp. 1737-1784 (Jun. 1955).
Woodward et al., "The Tissue Response to Implants and Its Evaluation by Light Microscopy;" CH 30, Handbook of Biomaterials Evaluation, Ed., pp. 364-378.
Miller et al., "Characterization of Biomedical Polymeradherent Macrophages: Interleukin 1 Generation and Scanning Electron Microscopy Studies", vol. 10, Apr. 1989 of Biomaterials, pp. 187-105.
Schruders, P. et al., "Normal wound healing compared to healing within preous Dacron implants;" Journal of biomedical Materials Research, vol. 22, pp. 121-135 (1989).
Korsmeyer, R. et al., "Effect of the Morphology of Hydrophilic Polmeric Matrices on the Diffusions and Release of Water Soluble Drugs:" Journal of Membrane Science, 9, pp. 211-227 (1981).
Reinhart, C. et al., "Solute diffusion in swollenmembranes. Part II. Influence of crosslinking on diffusive properties;" Journal of Membrane Science. 18 pp. 227-239 (1984).
Prohn, R.T. et al., "The Diffusion-Chamber Techniques Applied to a Study of the Nature of Homograft Persistance;" Journal of the National Cancer Institute, vol. 15, No. 3, pp. 509-517 (Dec. 1954).
Algire, G. H. et al., "Growth of Cells in Vivo in Diffusion Chambers. I. Survival of Homografts in Immunized Mice;" Journal of the National Cancer Institute, vol. 15 No. 3. pp. 493-506 (Dec. 1954).
Merwin, R.M. et al., "Fate of Vascularized and Nonvascularized Subcutaneous Homografts in Mice;" Journal of the National Cancer Institute, vol. 14, No. 4, pp. 819-839 (Feb. 1954).
Iwata, H., "The use of photocrosalinkable polyvinyl alcohol in the immunoisolation of pancreatic islets;" Transplantation Proceedings, vol. 22, No. 2 (Apr.), 1990 pp. 797-799.
Algire, G., "Diffusion-Chamber Techniques for studies of cellular immunity;" Annals New York Academy of Sciences, pp. 663-667.
Algire, G. et al. "Recent Developments in the Transparent-Chamber Techniques as Adapted to the Mouse;" Journal of the National Career Institute, vol. 10 No. 2, pp. 225-253 (Oct. 1949).

Affiliated with

Also associated with

Rating

Close vascularization implant material does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Close vascularization implant material, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Close vascularization implant material will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-265328